In a prospective crossover trial comparing unilateral with bilateral sacral neuromodulation for treatment of refractory voiding disorders, unilateral stimulation effectively relieved symptoms in 92% of patients.
According to Dr. W. A. Scheepens, of University Hospital Maastricht in The Netherlands, percutaneous nerve evaluation using both protocols can detect the minority of individuals in whom bilateral stimulation is preferable.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!